FDA announces actions regarding stem cell treatments – Lexology (registration)
|
FDA announces actions regarding stem cell treatments
Lexology (registration) Together with new guidance regarding the potential regulatory pathways for gene therapies, the FDA announced on Monday, August 28, 2017, that it will be taking action against companies providing unapproved stem cell treatments. This new guidance … |
